Leukemia, lymphoma, and HIV indications initial focus of targeted immune enhancement treatment using Caring Cross’ proprietary lentiviral vectors RIO DE JANEIRO and GAITHERSBURG, Md., March 26, 2024 /PRNewswire/ — Fundação Oswaldo Cruz (Fiocruz), a foundation from the Brazilian…
Fiocruz and Caring Cross Announce Collaboration Agreement to Enable Access to Affordable CAR-T Therapy in Brazil and Latin America
This post was originally published on this site